Effects of alemtuzumab on disability and cognition in patients with secondary progressive multiple sclerosis (SPMS)

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 3bded66ea1e6b249601ea8591d6164fd355bc52a
First added on: Feb 08, 2025